Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine involvement in the migraine attack.

M Fanciullacci1, M Alessandri, A Del Rosso

  • 1Department of Internal Medicine, Headache Centre, University of Florence, Italy.

Functional Neurology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silent thyroiditis following vaccination against COVID-19: report of two cases.

Journal of endocrinological investigation·2022
Same author

Recent advances in models for screening potential osteoporosis drugs.

Expert opinion on drug discovery·2018
Same author

Retroperitoneal approach for robot-assisted partial nephrectomy: technique and early outcomes.

International braz j urol : official journal of the Brazilian Society of Urology·2017
Same author

Rheumatologic rehabilitation: towards recommendations.

Reumatismo·2014
Same author

Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO study.

International journal of clinical practice·2014
Same author

Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.

Clinical and experimental rheumatology·2014
Same journal

The need for broader admission criteria for high specialty neurorehabilitation wards in the Italian Health System: not only post-comatose patients.

Functional neurology·2020
Same journal

The origins of the fight against rabies: a journey between the history of neuroscience and university museum collections.

Functional neurology·2020
Same journal

Are paediatric headaches in the emergency department increasing? An Italian experience.

Functional neurology·2020
Same journal

Neurophysiological changes after cognitive-motor tasks in Parkinson's disease patients with deep brain stimulation.

Functional neurology·2020
Same journal

Acute ischemic stroke management in Lebanon: obstacles and solutions.

Functional neurology·2020
Same journal

Does a single bout of exercise impacts BDNF, oxidative stress and epigenetic markers in spinal cord injury patients?

Functional neurology·2020
See all related articles

Dopamine plays a key role in migraine pathophysiology, with hypersensitive dopamine receptors contributing to symptoms. Blocking these hyperresponsive receptors may offer a new migraine therapy approach.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Clinical and genetic evidence suggests dopamine involvement in migraine.
  • Dopaminergic pathways may influence prodromal, accompanying, and postdromal migraine symptoms.

Purpose of the Study:

  • To investigate the role of dopamine in migraine pathophysiology.
  • To explore the potential of targeting dopaminergic pathways for migraine treatment.

Main Methods:

  • Review of clinical evidence and pharmacological findings.
  • Analysis of patient responses to dopaminergic agents (e.g., apomorphine, bromocriptine).
  • Neuroendocrine tests assessing dopaminergic control (e.g., prolactin secretion).

Main Results:

Related Experiment Videos

  • Migraine patients exhibit hypersensitivity to dopaminergic agents.
  • Dopamine receptor D5 density is increased in migraine sufferers.
  • Altered dopaminergic control of prolactin secretion observed in women with migraine.
  • Conclusions:

    • Hypersensitivity of peripheral and central dopamine receptors is a specific trait in migraine.
    • Dopaminergic activation may be a primary pathophysiological component in certain migraine subtypes.
    • Blocking hyperresponsive dopamine receptors presents a rationale for migraine therapy.